A ‘open study’ evaluation trial of the LIFE FLeX eHealth wellbeing program for anxiety and depression.

Not Applicable

Completed

• Conditions: Anxiety; Depression; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12615000480583
• Lead Sponsor: Federation University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Participants must be 18 years or older, have access to the internet, provide consent and be able to register online using an email address.

Exclusion Criteria

There are no key exclusion criteria.

LIFE FLeX has been written for people with depressive and anxiety symptoms and therefore recruitment will focus on people with depression and anxiety. However those without symptoms are able to register if they wish too (given this is a fully automated self help program). In addition, the program is also preventative in nature - thus 'healthy' participants may also benefit from some of the information within the program (e.g., increasing wellness flexibility).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety symptoms using the GAD-7 and specific anxiety disorder type questions (self developed)[Pre-intervention, during intervention (Week 2 and 5), post and 1 and 3 month follow-up];Depressive symptoms using the PHQ-9[Pre-intervention, during intervention (Week 2 and 5), post and 1 and 3 month follow-up]

Secondary Outcome Measures

Name	Time	Method
General psychological distress levels using the Kessler 6[Pre-intervention, post and 1 and 3 month follow-up];Emotional dysregulation by using the DERS[Pre-intervention, post and 1 and 3 month follow-up];Mental wellness using the MHC-SF[Pre-intervention, post and 1 and 3 month follow-up];Optimism using the LOT-R[Pre-intervention, post and 1 and 3 month follow-up];Quality of life using the EQ-5D[Pre-intervention, post and 1 and 3 month follow-up];Treatment credibility using the TCS[Pre-intervention];Treatment satisfaction, including engagement, will be measured using the TSQ[Post intervention];Demographic and lifestyle/personal questions using a self developed measure (e.g., age, gender, sleep, drug and alcohol use, exercise patterns)[Pre-intervention, post and 1 and 3 month follow-up]